MedCity Update – December 2014
View this email in your browser


From Sarah Haywood, Chief Operating Officer of MedCity

Although I know many of you already through my previous ‘unofficial’ work with MedCity, it’s a pleasure to say hello and introduce myself as the newly appointed Chief Operating Officer. I’m really proud of what we have achieved in the comparatively short time since our April launch, and the support and enthusiasm of our friends has been instrumental in getting us up and running so quickly, so huge thanks to you all.

There is a tangible sense of growing confidence across the life sciences sector, and we have big ambitions for 2015. This will include building on our work to promote innovation, entrepreneurship and investment in the sector and support businesses to set up operations here. Over the next few months we will be developing our communications materials, including the website, and I look forward to sharing our plans with you.

Finally, a reminder that our Angels in MedCity events for potential investors and investment-ready companies are continuing in January and February, so please join us and/or share through your networks. We are particularly keen to meet people who might be considering angel investment and we also want to work with people within the sector who could become lead angels in the future.

In the meantime, though, I wish you a happy and relaxing festive break from all at MedCity.

Government innovation review and Merck expansion

Merck will invest at least £42m in the south east over the next three years, with a new licensing hub in London, expanded research in Hertfordshire and clinical research in oncology and dementia.
At the same time, the UK government has announced a new Innovative Medicines and MedTech Review, aimed at speeding up patient access to new medical innovations.
Read more here

UK named world’s fourth most entrepreneurial economy

The UK has become Europe’s most entrepreneurial economy and has risen to fourth in the world, according to the 2015 edition of the Global Entrepreneurship Index. 

Read more

Put your business on the map with the Great Tech Census

The Mayor of London has commissioned a detailed analysis of London’s technology sector to support future policy-making. Please put your business on the map and help make sure that the capital’s vibrant, varied life sciences sector is properly represented by filling in the Great Tech Census.
Find out more and fill in the survey

Meet MedCity at Genesis 2014

Hear from Eliot Forster and Sarah Haywood plus Advisory Board members Jo Pisani and Simon Kerry at MedCity’s Breakfast Briefing from 8am at the Genesis conference.
MedCity is also sponsoring the Source Lounge – a relaxed space to find out more about potential partners, clients or investors. This year’s conference takes place on 9 December at the Queen Elizabeth II Conference Centre, Westminster.
See the full programme here

Visit London’s leading research and development centres

Wednesday 10 December
Various times
To complement Genesis, MedCity is coordinating a programme of Open House events at some of London’s most exciting and innovative research and commercialisation centres, including the Francis Crick Institute, the Cell Therapy Catapult, Imperial Innovations, King’s Health Partners and the Institute of Cancer Research. Participation is free but advance registration is essential.
Find out more and register with participating centres here

MedCity at Pharma Integrates

MedCity Executive Chair Eliot Forster and new Chief Operating Officer Sarah Haywood joined a range of life sciences experts at the two day Pharma Integrates conference.
See a round up of tweets from panel discussions on reinventing the pharma business model and staffing the future of pharma here

Spin-out spotlight: detecting early-stage lung cancer

A highly sensitive ‘breathalyser’ that can test for the tell-tale chemicals in the breath that indicate lung cancer is being developed by Owlstone Nanotech, a company spun out of research the founders carried out as Cambridge PhD students. Clinical testing of the device will take place in 2015, and the team hopes to have a product ready for use in 2017. 

Read more

BioBeat 14: 50 Movers and Shakers

50 Movers and Shakers identifies the top 50 women who are shaping biobusiness, including MedCity Advisory Board member and leading life sciences venture capitalist Kate Bingham. The report is produced by BioBeat, a partnership between Miranda Weston-Smith, Cambridge Judge Business School’s Centre for Entrepreneurial Learning and the Innovation Forum. 
Read more here

Coming up

Science as Revolution – Sir Paul Nurse, Natural History Museum
BioWales 2015, Welsh Government
London Regenerative Medicine Network December meeting
Venture research and other adventures, University College London
BIA Gala Dinner, BioIndustry Association


Email us to share your event

MedCity was established in April 2014 by the Mayor of London with the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCL Partners.

The next edition of MedCity Update will be sent in the first week of January 2015.



Copyright © 2014 MedCity. All rights reserved.